Neonatal fungal infections: When to treat?

Early Human Development

Volumn 88, Issue SUPPL.2, 2012, Pages

  Hsieh, E ^a,b   Smith, P B ^b,c   Jacqz Aigrain, E ^d   Kaguelidou, F ^d   Cohen Wolkowiez, M ^b,c   Manzoni, P ^e   Benjamin, Jr ^b,c  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e S ANNA HOSPITAL   (Italy)

Author keywords

Antifungal therapy; Candida; Empirical; Infection; Neonatal intensive care unit

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANIDULAFUNGIN; CARBAPENEM; CASPOFUNGIN; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; MICAFUNGIN;

ANTIBIOTIC THERAPY; BLOODSTREAM INFECTION; CANDIDIASIS; CLINICAL TRIAL; HIGH RISK INFANT; HUMAN; INTRAVENOUS CATHETER; LONG TERM CARE; LOW BIRTH WEIGHT; NEWBORN INFECTION; REVIEW; RISK FACTOR; SYSTEMIC MYCOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CANDIDIASIS, INVASIVE; CENTRAL NERVOUS SYSTEM INFECTIONS; CENTRAL VENOUS CATHETERS; CEPHALOSPORINS; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84861465491     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(12)70004-X     Document Type: Review

References (26)

1. Benjamin DK, DeLong ER, Cotton CM, Garges HP, Steiback WJ, Clark RH Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol 2004, 24:175-180.
2. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982, 72:101-111.
3. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993, 17:103-109.
4. Benjamin DK, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010, 126:e865-e873.
5. Benjamin DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117:84-92.
6. Kaufman D, Fairchild KD Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004, 17:638-680.
7. Benjamin DK, DeLong ER, Steiback WJ, Cotton CM, Walsh TJ, Clark RH Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 2003, 112:543-547.
8. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin T, Dawson J, et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J 2000, 19:319-324.
9. Kaufman D Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol 2003, 27:414-424.
10. Johnson DE, Thompson TR, Green TP, Ferrieri P Systemic candidiasis in very low birth weight infants (<1500 grams). Pediatrics 1984, 73:138-143.
11. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006, 118:717-722.
12. Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis 2009, 38:1042-1051.
13. Schiel X, Link H, Maschmeyer G, Glass B, Cornely OA, Buchheidt D, et al. A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society of Chemotherapy (PEG) multicenter trial II. Infection 2006, 34:118-126.
14. Morrell M, Fraser VJ, Kollef MH Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645.
15. Benjamin DK, Ross K, McKinney RE, Benjamin DK, Auten R, Fisher RG When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000, 106:712-718.
16. Eggimann P, Garbino J, Pittet D Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003, 3:772-785.
17. Smith PB, Steinbach WJ, Benjamin DK Invasive Candida infections in the neonate. Drug Resist Updat 2005, 8:147-162.
18. Cohen-Wolkowiez M, Smith PB, Manhum B, Steinback WJ, Alexander BD, et al. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J Perinatol 2007, 27:97-100.
19. Friedman S, Richardson SE, Jacobs SE, O'Brien K Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 2000, 19:499-504.
20. Lee BE, Cheung PY, Robinson JL, Evanochko C, Robertson CM Comparative study of mortality and morbidity in premature infants (birth weight <1250g) with candidemia or candidal menigitis. Clin Infect Dis 1998, 27:559-565.
21. Stoll BJ, Hansen N, Fanaroff AA, Wright L, Carlo WA, Ehrenkranz RA, et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004, 113:1181-1186.
22. Phillips JR, Karlowicz MG Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J 1997, 16:190-194.
23. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161-189.
24. Wynn JL, Tan S, Gantz MG, Das A, Goldberg RN, Adams-Chapman I, Stoll BJ, NICHD Neonatal Research Network, et al. Outcomes following candiduria in extremely low birth weight infants. Clin Infect Dis 2012, 54(3):331-339.
25. Brammer KW, Farrow PR, Faulkner JW Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 1990, 12:318-326.
26. Wong-Beringer A, Jacobs RA, Guglielmo BJ Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 1998, 27:603-618.